IMPLEMENTATION OF AN END-TO-END CONTINUOUS BIOPROCESSINGPLATFORM USING NOVEL TECHNOLOGIES

摘要

One significant opportunity for evolutionary change in the biopharmaceutical industry is the widespread adoption of integrated continuous bioprocessing for biologies manufacturing. Key to its success is the availability of novel upstream and downstream technologies that will not only reduce facility footprint, capital expenses and product cost of goods (CoGs), but also will increase process productivity, flexibility and further facilitate the utilization of single-use and/or disposable technologies.